Delivery Order SPE2DB20D2014-SPE2DB25FC58M
- Not listed
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,571.97 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop in 2ML units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.60 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) with a ceiling value of $2,509.24. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $8,218.23 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of VEVYE 0.1% eye drops in 2ml quantities. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,438.39 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,519.02 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Vevye 0.1% eye drop solution (2ML units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,103.46 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) with a ceiling value of $1,715.49 under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC58MDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,047.98 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2mL) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical vendor within the federal medical supply chain, particularly for military and veteran healthcare systems. This delivery order for ophthalmic medication exemplifies the company's role in supplying diverse pharmaceutical products and medical commodities across multiple therapeutic domains to support Department of Defense healthcare programs. The contract utilizes no set-aside designation, confirming award through open competition in accordance with standard federal procurement practices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/28/25 |